SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
CAMBRIDGE NEUROSCIENCE, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
13242610
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of Pages
<PAGE>
SCHEDULE 13G
- -----------------------------------------------------------------------------
CUSIP No. 13242610 Page OF PAGES
- -----------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Warburg, Pincus Capital Partners Liquidating Trust
- ----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a)
(b) X
- ----------------------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
- ----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
- ----------------------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY 0
- ----------------------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING 0
- ----------------------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH 0
- ----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
- ----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES*
- ----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0
- ----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
- ----------------------------------------------------------------------------
* SEE INSTRUCTIONS BEFORE FILING OUT!
<PAGE>
ITEM 1(A). NAME OF ISSUER:
Cambridge NeuroScience, Inc.
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
One Kendall Square
Building 700
Cambridge, MA 02139
Items 2(a),
(B) AND (C). NAME OF PERSON FILING; ADDRESS OF PRINCIPAL BUSINESS
OFFICE; CITIZENSHIP:
This statement is being filed by Warburg, Pincus Capital Partners
Liquidating Trust (the "Trust"), whose business address is 466 Lexington Avenue,
New York, New York 10017.
ITEM 2(D). TITLE OF CLASS OF SECURITIES:
Common Stock
ITEM 2(E). CUSIP NUMBER:
13242610
ITEM 3. Not Applicable
ITEM 4. OWNERSHIP:
(a) 0
(b) 0
(c) (i) 0
(ii) 0
(iii) 0
(iv) 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
At the date hereof, the Trust has ceased to be the beneficial
owner of more than 5% of the Common Stock.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON:
Not Applicable
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY:
Not Applicable
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
Not Applicable
ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
Not Applicable
ITEM 10. CERTIFICATION:
Not Applicable
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
WARBURG, PINCUS CAPITAL PARTNERS LIQUIDATING TRUST
By:/s/ Stephen Distler
Stephen Distler, Trustee
Dated: April 21, 1998
